South Dakota Attorney General Opinion: Federal Marijuana Rescheduling Won’t Alter State’s Medical Program
South Dakota's Attorney General has issued an opinion stating that the federal rescheduling of marijuana will not impact the state's existing medical marijuana program.
Sioux Falls, SD, October 13, 2026 — The office of South Dakota’s Attorney General has issued a formal opinion clarifying that anticipated federal rescheduling of marijuana will not affect the state’s current medical marijuana program. The opinion states that changes at the federal level will not alter the existing legal framework governing medical cannabis within South Dakota.
The precise details of the federal rescheduling were not specified in the provided information, nor was the exact date the Attorney General’s opinion was issued. However, the core assertion from the state’s top legal official is that South Dakota’s established medical marijuana laws and regulations will remain in place irrespective of federal policy shifts.
South Dakota voters approved a medical marijuana initiative in November 2020. The state’s program subsequently established rules and processes for the cultivation, sale, and use of marijuana for registered patients with qualifying medical conditions. The Attorney General’s opinion serves to assure stakeholders, including patients, providers, and law enforcement, that the state’s program is currently insulated from potential federal adjustments.
The opinion did not elaborate on any specific federal proposals or actions that prompted this clarification. It also did not detail any potential future legislative actions the state might consider in response to federal changes. The contractor’s name, if applicable to the opinion’s development, was not provided. The contractor’s name was not provided. The fine amount was not provided.
Further information regarding the specific federal rescheduling context or any potential implications not covered by the opinion was not available. The primary takeaway from the Attorney General’s office is a directive that the state’s medical marijuana program will continue to operate under its current statutes.
Story summarized from the original created by Marissa Brunkhorst on www.keloland.com, see more information here.
Media gallery
